Black Box Trading

This forecast is part of the Stocks Under 20 Dollars Package, as one of I Know First’s forecast services. The full package includes daily stock predictions for a total of 20 stocks with bullish and bearish signals:

• Top 10 stocks for the long position
• Top 10 stocks for the short position

Package Name: Stocks Under 20 Dollars
Recommended Positions: Long
Forecast Length: 7 Days (05/09/2017 – 05/16/2017)
I Know First Average: 9.93%

I Know First’s State of the Art Algorithm accurately forecasted 8 out of 10 trades in this Stocks Under 20 Dollars Package for the 7 Days time period. The greatest return came from VRX at 45.01%. DDD and BZH also performed well for this time horizon with returns of 22.62% and 11.17%, respectively. The package itself saw an overall return of 9.93%, providing investors with a 9.88% premium above the S&P 500’s return of 0.05% for the same time period.

Valeant Pharmaceuticals International, Inc. (VRX) develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, as well as Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications. Further, it provides Tobramycin and Dexamethasone ophthalmic suspension for steroid responsive inflammatory ocular conditions; Metronidazole to treat bacterial infections; and Latanoprost for the treatment of glaucoma. Valeant Pharmaceuticals International, Inc. (VRX) was founded in 1983 and is headquartered in Laval, Canada.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.